Bronchial Mucus in COPD and Cystic Fibrosis
Conditions
Brief summary
Patients for whom bronchial mucus collection has been performed as part of the treatment will be offered the opportunity to participate in the study. * A rheology measurement will be carried out shortly after the collection of fresh bronchial mucus samples. * Another part will be done on frozen bronchial mucus samples
Interventions
BIOLOGICALbronchial mucus collection
mucus resulting from respiratory physiotherapy sessions for patients with cystic fibrosis or COPD, bronchial aspirations resulting from the bronchial fibroscopy programme
Sponsors
University Grenoble Alps
University Hospital, Grenoble
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Male or female over 18 years of age. * Patient consulting or hospitalised in the pneumology department and for whom an emission of bronchial mucus is planned as part of the treatment (mucus from respiratory physiotherapy sessions for patients with cystic fibrosis or COPD, bronchial aspirations from the bronchial fibroscopy programme).
Exclusion criteria
* Patient being opposed to the use of his mucus samples and data for this research. * Patient protected by law (guardianship or curatorship), subject deprived of liberty
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reproducibility of the rheology parameters studied | Day 1 | Establish operating protocols for obtaining reliable rheological measurements with a view to using them as biomarkers |
Outcome results
None listed